Cerus Corp (CERS) is a publicly traded Healthcare sector company. As of August 26, 2026, CERS trades at $2.76 with a market cap of $548.15M and a P/E ratio of -90.83. CERS moved +1.10% today. Year to date, CERS is +39.09%; over the trailing twelve months it is +106.02%. Its 52-week range spans $1.12 to $3.47. Analyst consensus is buy with an average price target of $4.50. Rallies surfaces CERS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CERS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.76 |
| Market Cap | $548.15M |
| P/E Ratio | -90.83 |
| EPS | $-0.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.47 |
| 52-Week Low | $1.12 |
| Volume | 951.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $277.20M |
| Net Income | $-6.83M |
| Gross Margin | 0.00% |
2 analysts cover CERS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.50.